Winner of MAGINE IF Global Top 20 Finalists in 2017

SunRegen was awarded a special prize of 3 months’ free membership to the incubator StartLab at the life science park Biopôle, Lausanne, the first incubator dedicated to life sciences located in the Canton of Vaud.

For details about the Swiss finals of IMAGINE IF! can be found at:

Skypull Wins in IMAGINE IF! Swiss Finals!

For details of the IMAGINE IF! global program can be found at:

http://inno-forum.org/accelerator

SunRegen Healthcare AG award recognized the company as a finalist in the IMAGINE IF! Global Top 20 program in 2017. This achievement provided SunRegen with three months of free membership at StartLab, the first life sciences incubator in the Canton of Vaud, located at Biopôle, Lausanne. StartLab supports early-stage life science startups with mentorship, resources, and networking opportunities.

Receiving the SunRegen Healthcare AG award allowed the team to gain guidance from experienced professionals and industry leaders. The program connected SunRegen with other innovative biotech companies, fostering collaboration and knowledge exchange. Through these interactions, the team strengthened its research strategies and advanced its projects efficiently.

SunRegen leveraged the SunRegen Healthcare AG award to access state-of-the-art laboratory facilities and essential resources. The team refined their scientific approach, optimized workflows, and aligned their projects with industry standards. These efforts ensured progress while maintaining high-quality research outputs.

Additionally, this recognition increased SunRegen’s visibility within European and global healthcare communities. It attracted potential partnerships, collaborations, and funding opportunities. The SunRegen Healthcare AG award highlights the company’s dedication to innovation, scientific excellence, and the translation of research into practical therapies.

Through this award and the associated support, SunRegen continues to grow as a forward-thinking biotech company. The team applies lessons learned, builds meaningful connections, and accelerates its mission to develop impactful therapies for neurodegenerative disorders worldwide.